← Evidence map

ReviewFrontiers in oncology2022

Overview on population screening for carriers with germline BRCA mutation in China.

Huijun Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36439508